The Readout Loud
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
251
Episode 148: Akshay Sharma on gene therapy's se...
We discuss all that and more this week on “The Re…
35 min
252
Episode 147: David Fajgenbaum on Covid-19 drugs...
When will we have enough vaccine doses? How many …
35 min
253
Episode 146: Paul Offit on vaccine data, 23andM...
We discuss all that and more this week on “The Re…
34 min
254
Episode 145: Kevin Davies on the CRISPR boom, &...
First, we discuss the implications of Johnson & J…
34 min
255
Episode 144: Remembering STAT's Sharon Begley
We're spending this entire episode remembering Sh…
39 min
256
Episode 143: #JPM21: Déjà vu in Alzheimer's res...
We're devoting this episode to the news coming ou…
29 min
257
Episode 142: Bob Nelsen on the pandemic's next ...
On this year's first episode, STAT Washington cor…
29 min
258
Episode 141: Moderna's vaccine milestone, Warp ...
It's the final episode of 2020. We dig into the s…
34 min
259
Episode 140: Pfizer's Covid-19 vaccine — the de...
Are Covid-19 vaccines safe for teens? Is the U.S.…
33 min
260
Episode 139: Angela Rasmussen on AstraZeneca's ...
Can too much Covid-19 vaccine be a bad thing? Is …
28 min
261
Episode 138: The latest Covid-19 vaccine, Biden...
How do we measure whether Covid-19 vaccines work?…
23 min
262
Episode 137: Natalie Dean on Pfizer's Covid-19 ...
How well does Pfizer's Covid-19 vaccine work? Wha…
29 min
263
Bracing for a pandemic winter, Biogen's fortune...
How bad will this winter be? Is everything coming…
26 min
264
Episode 135: Pfizer's Covid-19 mystery, Ashish ...
When are we getting Covid-19 vaccine data? Will c…
29 min
265
Episode 134: Erik Gordon on SPACs, plus Covid-1...
Who's voice rings loudest at the FDA? Is it wise …
24 min
266
Episode 133: A week of pauses, pharma’s stateho...
Is your local lawmaker flush with pharma cash? Ho…
28 min
267
Episode 132: How Trump's case of Covid-19 affec...
Why is the president making drug ads? Are antibod…
23 min
268
Episode 131: Saad Omer on Covid-19 vaccine tria...
Can an itchy arm ruin a clinical trial? Does inte…
25 min
269
Episode 130: A road map for Covid-19, the gold ...
Is superspreading an Olympic event? Will Covid-19…
25 min
270
Episode 129: Heidi Tworek on pandemic PR, plus...
How should governments talk about Covid-19? Can t…
26 min
271
Episode 128: AstraZeneca’s Covid-19 vaccine, co...
Is AstraZeneca’s Covid-19 vaccine in jeopardy? Wh…
25 min
272
Episode 127: Eric Topol on Stephen Hahn, plus C...
Should the FDA commissioner resign? How fast can …
24 min
273
Episode 126: The FDA's chaotic week, Trump's ef...
Can the Food and Drug Administration survive Trum…
24 min
274
Episode 125: Shocking FDA rejections, a longevi...
Did the FDA suddenly get stringent about new drug…
19 min
275
Episode 124: Pharma's lobbying dollars, Alnylam...
Is pharma scared of Kamala Harris? Are there seco…
26 min